94322 ⎘
Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups - condensed with carbocyclic rings or ring systems; Ortho- or peri-condensed ring systems; Ring systems of three rings containing carbocyclic rings other than six-membered
POLYCYCLIC COMPOUND AND USE THEREOF
#2QUINOLINE DERIVATIVES AND USES IN MANAGING CANCER
#3CYCLOOCTYNES FOR CLICK CHEMISTRY
#4ISOQUINOLINE DERIVATIVES FOR USE IN THERAPY
#5SMALL-MOLECULE INHIBITORS OF THE FRS2-FGFR INTERACTION AND THEIR USE IN MEDICINE, IN THE PREVENTION AND TREATMENT OF CANCER
#6TRICYCLIC HETEROARENES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME, AND METHODS OF USING THE SAME
#7TRICYCLIC COMPOUNDS, PREPARATION METHOD AND MEDICAL USE THEREOF
#8TRICYCLIC SULFONES AS ROR GAMMA MODULATORS
#9COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY
#10Cyclooctynes for click chemistry
#11NLRP MODULATORS
#12Compositions and methods for decreasing, or preventing or reversing gain of, skin pigmentation in a mammalian subject
#13Photostabilizing compounds, compositions, and methods
#14PHARMACEUTICAL FORMULATIONS CONTAINING IPIDACRINE AND THEIR USE FOR THE TREATMENT OF DISORDERS OF POTENCY AND DISORDERS OF OTHER FORMS OF SEXUAL ACTIVITY
#15INDENOPYRIDINE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME
#16Compositions and methods for decreasing, or preventing or reversing gain of, skin pigmentation in a mammalian subject
#17Autophagy inhibitors
#18COMPOSITIONS AND METHODS FOR INCREASING, OR PREVENTING OR REVERSING LOSS OF, SKIN PIGMENTATION IN A MAMMALIAN SUBJECT
#19Organic molecules having two non-conjugated bridges between a donor and an acceptor for effective thermally activated delayed fluorescence for use in optoelectronic devices
#20SHIP1 MODULATORS AND METHODS RELATED THERETO
#21SHIP1 modulators and methods related thereto
#22SHIP1 MODULATORS AND METHODS RELATED THERETO
#23Ligands for alpha-7 nicotinic acetylcholine receptors and methods of treating neurological and inflammatory conditions
#24Antidiabetic tricyclic compounds
#25Use of small molecule inhibitors targeting the interaction between RAC GTPase and p67
#26Aryl- and heteroarylcarbonyl derivatives of hexahydroindenopyridine and octahydrobenzoquinoline
#27Antidiabetic tricyclic compounds
#28Heterocyclic compounds
#29Methods of making 2-halonicotinonitriles
#30Antidiabetic tricyclic compounds
#31HISTONE DEACETYLASE INHIBITORS BASED ON DERIVATIVES OF TRICYCLIC POLYHYDROACRIDINE AND ANALOGS POSSESSING FUSED SATURATED FIVE-AND-SEVEN-MEMBERED RINGS
#32SHIP1 modulators and methods related thereto
#33Inhibitors of protein phosphatase-1 and uses thereof
#34PHARMACEUTICAL FORMULATIONS CONTAINING IPIDACRINE AND THEIR USE FOR THE TREATMENT OF DISORDERS OF POTENCY AND DISORDERS OF OTHER FORMS OF SEXUAL ACTIVITY
#35NOVEL ANTIVIRAL COMPOUNDS
#36Antidiabetic tricyclic compounds
#37Tricyclic compounds and PBK inhibitors containing the same
#38Indenopyridine-based compound and organic light-emitting device including the same
#39Use of small molecule inhibitors targeting the interaction between Rac GTPase and p67 (phox)
#40INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION
#41Autophagy inhibitors
#42CYCLOALKYL-FUSED TETRAHYDROQUINOLINES AS CRTH2 RECEPTOR MODULATORS
#43Indenopyridine derivatives
#44Bicyclic nitrogen containing heteroaryl TGR5 receptor modulators
#45Quinolone compound and pharmaceutical composition
#46ANTIDIABETIC TRICYCLIC COMPOUNDS
#47Phenyl-tetrahydroisoquinoline derivatives
#48Premature-termination-codons readthrough compounds
#49Antiviral compounds
#50Indenopyridine derivatives
#51Tricyclic compounds and PBK inhibitors containing the same
#52Fused ring pyridine compound
#53Arylsulfonamide based matrix metalloprotease inhibitors
#54Quinolone compound and pharmaceutical composition
#55Cycloalkyl-fused tetrahydroquinolines as CRTHreceptor modulators
#56Arylsulfonamide based matrix metalloprotease inhibitors
#57METHODS FOR THE TREATMENT OF TUMORS WITH INDANE COMPOUNDS
#58Azafluorene derivative and organic light-emitting device using the derivative
#59Metal complex compound and organic light emitting diode device including the same
#60Quinolone compound and pharmaceutical composition
#61Aryl- and heteroarylcarbonyl derivatives of hexahydroindenopyridine and octahydrobenzoquinoline
#62Compounds for binding to ER alpha/beta and GPR30, methods of treating disease states and conditions mediated through these receptors and identification thereof
#63NOVEL TRICYCLIC PROTEIN KINASE MODULATORS
#64Arylsulfonamide-based matrix metalloprotease inhibitors
#65Inhibitors of human immunodeficiency virus replication
#66Fused indane compound
#67Acylguanidine derivative or salt thereof
#68Pyridone derivatives having a binding activity to the cannabinoid type 2 receptor
#69Condensed tetrahydroquinoline derivative and use thereof for medical purposes
#70Pyrene compounds and organic electroluminescent devices using the same
#71Benzofluoranthene compound and organic light-emitting device using the compound
#72Inhibitors of protein phosphatase-1 and uses thereof
#735-HTreceptor antagonists
#74ANTISPERMATOGENIC, SPERMICIDAL AND/OR ANTIFUNGAL COMPOSITION AND METHODS OF USING THE SAME
#75SUBSTITUTED TETRAHYDROQUINOLINES AS ANTIBACTERIAL AGENTS
#76Tyrosine kinase inhibitors
#77Benzocycloheptapyridines as inhibitors of the receptor tyrosine kinase MET
#78Aminoindane derivative or salt thereof
#79Dye-sensitized photoelectric conversion device
#80TRICYCLIC STEROID HORMONE NUCLEAR RECEPTOR MODULATORS
#81OLED device employing alkali metal cluster compounds
#82Pyridine based compounds useful as intermediates for pharmaceutical or agricultural end-products
#83NOVEL 2-QUINOLONE DERIVATIVE
#84INDANES
#85Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methods
#865-HTreceptor antagonists
#87Tyrosine kinase inhibitors
#88Benzo(GHI)fluoranthene derivative and organic light emitting device using the same
#89Tetrahydroquinoline derivatives
#90PREPARATION OF LORATADINE FORM I
#91Compounds for binding to ERα/β and GPR30, methods of treating disease states and conditions mediated through these receptors and identification thereof
#92Azafluorene derivative and organic light-emitting device using the derivative
#93Compositions and methods for modulating gated ion channels
#94Substituted N-Aryl-1H-Pyrazolo[3,4-B]Quinolin-4-Amines and Analogs as Activators of Caspases and Inducers of Apoptosis
#95HMG-CoA reductase inhibitors
#96Farnesyl protein transferase inhibitors
#97Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methods
#98Tetrahydroquinolines, synthesis thereof, and intermediates thereto
#99Substituted tricyclic heterocycles as serotonin receptor agonists and antagonists
#100Diazepinoquinolines, synthesis thereof, and intermediates thereto
#101Tyrosine kinase inhibitors
#102Antibiotic cycloalkyltetrahydroquinoline derivatives
#103Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
#104Arylindenopyridines and related therapeutic and prophylactic methods
#1055-HT7 receptor antagonists
#106Androgen receptor agonists
#107Enantioselective process
#108Compounds for the treatment of inflammatory disorders
#109Indole inhibitors of 15-lipoxygenase
#110Tricyclic steroid hormone nuclear receptor modulators
#111Pyridone derivatives having a binding activity to the cannabinoid type 2 receptor
#112Amide derivatives and nociceptin antagonists
#113Arylindenopyridines and related therapeutic and prophylactic methods
#114Non-imidazole tertiary amines as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other CNS disorders
#115Novel tetrahydroquinoline derivatives
#116Arylindenopyridines and related therapeutic and prophylactic methods
#117Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methods
#118Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methods
#119Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methods
#1204-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines
#121Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methods
#122Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methods
#123Arylindenopyridines and related therapeutic and prophylactic methods
#124Metabotropic glutamate receptor antagonists
#125Process for preparing chiral diol sulfones and dihydroxy acid HMG CoA reductase inhibitors
#126Metal coordination compound and electroluminescence device
#127Aminoquinoline compounds
#128Method for the production of substituted 1,2,3,4-tetrahydroquinoline-2-carboxylic acids
#129Cyclooctynes for click chemistry